InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Kawakami Mark. Director active across 1 company, notably Arcadia Biosciences, Inc.. In total, 2 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €3k. Activity tracked since 1 August 2024. The latest transaction was filed on 3 February 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations